subject: CHEBI:145499

subject_name: Donepezil

object_name: Neuropathic pain


subject: CHEBI:188719

subject_name: Ertugliflozin

object_name: kidney failure

tested_intervention: yes


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: diffuse large B-cell lymphoma


subject: UNII:SQ8A3S5101

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:SQ8A3S5101

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:94782

subject_name: Cediranib

object_name: Refractory Differentiated Thyroid Gland Carcinoma

tested_intervention: unsure


subject: CHEBI:94782

object_name: Refractory Thyroid Gland Follicular Carcinoma


subject: CHEBI:94782

object_name: Refractory Thyroid Gland Papillary Carcinoma


subject: CHEBI:94782

object_name: Refractory Thyroid Gland Oncocytic Carcinoma


subject: CHEBI:94782

object_name: Unresectable Thyroid Gland Carcinoma


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: PUBCHEM.COMPOUND:56952080

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:56952080

object_name: major depressive disorder


subject: DRUGBANK:DB18907


subject: DRUGBANK:DB18907


subject: CHEBI:31401

subject_name: Cilostazol

object_name: osteoarthritis


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Peri-implant mucositis


subject: UNII:Z5MR2Y1IJJ

subject_name: Enavogliflozin

object_name: cardiovascular disorder


subject: UNII:Z5MR2Y1IJJ

object_name: kidney disorder


subject: CHEBI:182159

subject_name: Cannabidivarin

object_name: Prader-Willi syndrome


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: Advanced Bile Duct Carcinoma


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UNII:MFI2XG2PVK

object_name: REM sleep behavior disorder


subject: CHEBI:141426

subject_name: Asp-Met

object_name: hypertension


subject: CHEBI:141426

object_name: Hypertension, CTCAE


subject: CHEBI:141426

object_name: type 2 diabetes mellitus


subject: CHEBI:141426

object_name: HIV infection


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:70839

subject_name: Dasatinib

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:91512

object_name: acute lymphoblastic leukemia


subject: CHEBI:91512


subject: PUBCHEM.COMPOUND:3628

subject_name: homoharringtonine


subject: PUBCHEM.COMPOUND:3628


subject: CHEBI:71019

subject_name: omacetaxine


subject: CHEBI:71019


subject: UMLS:C3852655

object_name: hepatitis C


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: CYP2D6 polymorphism


subject: CHEBI:146178

subject_name: RACEMETHORPHAN


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470


subject: UMLS:C0722264

subject_name: Ontak

object_name: male breast carcinoma


subject: UMLS:C0722264

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C0722264

object_name: Carcinoma breast stage IV


subject: UMLS:C0722264

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C0722264

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C0722264

object_name: Breast cancer recurrent


subject: UMLS:C0722264

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C0722264

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C0722264

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C0722264

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C0722264

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C0722264

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C0722264

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C0722264

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C0722264

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C0722264

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: colorectal neoplasm


subject: CHEBI:94686

subject_name: Orlistat

object_name: hypertriglyceridemia


subject: CHEBI:94686

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:28240

subject_name: dichloroacetate

object_name: diabetic hyperglycaemia


subject: CHEBI:36386

subject_name: Dichloroacetic acid


subject: UMLS:C3181055

object_name: kidney failure


subject: PUBCHEM.COMPOUND:156963498

subject_name: Mecapegfilgrastim

object_name: Carcinoma breast stage IV


subject: UNII:I4QL0KKG3K

subject_name: pegylated granulocyte colony-stimulating factor


subject: CHEMBL.COMPOUND:CHEMBL5095279

subject_name: MECAPEGFILGRASTIM


subject: UMLS:C3179328


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Arterial thrombosis


subject: CHEBI:75551

object_name: psychosexual disorder


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Achilles tendon pain


subject: CHEBI:8988

object_name: Stage II Colon Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage II Colon Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage II Colon Cancer


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: CHEBI:75179

subject_name: Trifluridine

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:75179

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:75179

object_name: Stage III Colon Cancer


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: UNII:DQY244459T

object_name: alcohol abuse


subject: UNII:DQY244459T

object_name: alcohol dependence


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: genetic disease


subject: CHEBI:5118

object_name: Rare Diseases


subject: CHEBI:4445

subject_name: Desflurane

object_name: brain ischemia


subject: CHEBI:4445

object_name: cerebral infarction


subject: UNII:S276568KOY

subject_name: Gadopiclenol

object_name: congenital heart disease


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: Oral Pain


subject: PUBCHEM.COMPOUND:9848990

object_name: Pain of region of internal part of mouth


subject: CHEBI:64356

subject_name: Pregabalin

object_name: Neck Carcinoma


subject: CHEBI:64356

object_name: head and neck neoplasm


subject: CHEBI:64356

object_name: head and neck cancer


subject: GTOPDB:4934

subject_name: G-CSF

object_name: triple-negative breast carcinoma


subject: GTOPDB:4934

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB


subject: UNII:6XG22YQM2Z


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: CHEBI:37144

subject_name: epichlorohydrin

object_name: endogenous depression


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: UMLS:C4745029

subject_name: HLX 10

object_name: HER2-positive gastric cancer


subject: UNII:Q91187K011

subject_name: Tetraferric tricitrate decahydrate

object_name: phosphorus metabolism disease


subject: CHEBI:144421

subject_name: ferric citrate


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: pancreatic neoplasm


subject: MESH:C000629782

object_name: exocrine pancreatic carcinoma


subject: MESH:C000629782

object_name: malignant pancreatic neoplasm


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UMLS:C3896914

object_name: neoplasm


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:67RM91WDHQ

subject_name: Onvansertib


subject: UMLS:C0939403

subject_name: NIFEdipine ER

object_name: hypertension, pregnancy-induced


subject: UMLS:C0939403

object_name: Maternal hypertension


subject: UMLS:C0939403

object_name: preeclampsia postpartum


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: Procedural anxiety


subject: CHEBI:17045

object_name: Pain, Procedural


subject: CHEBI:71223

subject_name: Pralatrexate

object_name: adult lymphoma


subject: CHEBI:71223

object_name: lymphoma


subject: CHEBI:71223

object_name: pediatric lymphoma


subject: CHEBI:71223

object_name: Hodgkin Disease


subject: CHEBI:71223

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:71223

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:71223

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:71223

object_name: non-Hodgkin lymphoma


subject: CHEBI:71223

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:71223

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:71223

object_name: plasma cell myeloma


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: RXCUI:797752

subject_name: hepatitis B surface antigen vaccine 0.02 MG/ML

object_name: hepatitis B


subject: RXCUI:797752

object_name: liver cirrhosis


subject: RXCUI:797752

object_name: Chronic liver disease


subject: CHEBI:8389

subject_name: conjugated estrogens

object_name: prostate carcinoma


subject: CHEBI:8389

object_name: prostate cancer


subject: CHEBI:17474

subject_name: Estrone sulfate


subject: CHEBI:17474


subject: PUBCHEM.COMPOUND:45357473

subject_name: Estratab


subject: PUBCHEM.COMPOUND:45357473


subject: UMLS:C5446601

subject_name: pNGVL4a-CRT-E6E7L2 DNA Vaccine

object_name: uterine cervix carcinoma in situ


subject: UMLS:C5446601

object_name: Cervical intraepithelial neoplasia grade 2


subject: UMLS:C4287749

subject_name: Onvatilimab

object_name: Advanced cancer


subject: GTOPDB:12907

subject_name: bexmarilimab

object_name: renal cell carcinoma


subject: GTOPDB:12907

object_name: colon carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594544

subject_name: BEXMARILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594544


subject: UMLS:C5204510


subject: UMLS:C5204510


subject: UMLS:C3467925

object_name: hepatic; functional disturbance


subject: CHEBI:82975

subject_name: Naloxegol


subject: MESH:D002214

subject_name: Capsules

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:8080

subject_name: Phentermine

object_name: kidney failure


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Primary malignant neoplasm


subject: CHEBI:52717

object_name: childhood malignant neoplasm


subject: CHEBI:52717

object_name: Malignant obstetric neoplasm


subject: CHEBI:52717

object_name: Hepatic Complication


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: HIV-1 infection


subject: CHEBI:15940

subject_name: Niacin


subject: CHEBI:17154

subject_name: Nicotinamide


subject: UMLS:C1541801

subject_name: TroVax

object_name: colorectal neoplasm


subject: UMLS:C5940911


subject: UMLS:C2607038

object_name: mild neurocognitive disorder


subject: UMLS:C2607038

object_name: mild cognitive impairment


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: pancreatic neoplasm


subject: CHEBI:68579

object_name: exocrine pancreatic carcinoma


subject: CHEBI:68579

object_name: malignant pancreatic neoplasm


subject: CHEBI:68579

object_name: Cancer-associated thrombosis


subject: CHEBI:68579

object_name: Plexosarcoma


subject: CHEBI:68579

object_name: Duodenal Cancer


subject: CHEBI:68579

object_name: carcinoma of duodenum


subject: CHEBI:68579

object_name: duodenum cancer


subject: CHEBI:68579

object_name: ampulla of vater cancer


subject: CHEBI:68579

object_name: carcinoma of the ampulla of vater


subject: CHEBI:68579

object_name: Stomach cancer


subject: CHEBI:68579

object_name: gastric cancer


subject: CHEBI:68579

object_name: carcinoma of esophagus


subject: CHEBI:68579

object_name: esophageal cancer


subject: CHEBI:68579

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:68579

object_name: neoplasm of esophagus


subject: CHEBI:68579

object_name: liver carcinoma


subject: CHEBI:72296

subject_name: Apixaban


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:72296


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Irritability


subject: CHEBI:42797

object_name: Digestive System Signs and Symptoms


subject: CHEBI:137064

subject_name: Galunisertib

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:31689

subject_name: Iguratimod

object_name: lupus nephritis


subject: CHEBI:230905

subject_name: Ribociclib

object_name: drug-induced liver injury


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:233362

subject_name: Abemaciclib


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: liver cancer


subject: PUBCHEM.COMPOUND:3080587

object_name: liver neoplasm


subject: PUBCHEM.COMPOUND:3080587

object_name: Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:3080587


subject: UMLS:C4721962

object_name: neuralgia


subject: UMLS:C4721962

object_name: Neuralgia, CTCAE


subject: CHEBI:71013

subject_name: Perampanel


subject: CHEBI:71013


subject: PUBCHEM.COMPOUND:3367

object_name: Wiskott-Aldrich syndrome


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: PUBCHEM.COMPOUND:46874763

object_name: sinusitis


subject: PUBCHEM.COMPOUND:46874763

object_name: Sinusitis, CTCAE


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: CHEBI:6904

subject_name: Metoprolol

object_name: Nasal Polyp


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:75722

subject_name: Tramadol


subject: UMLS:C5448030

subject_name: Rose Geranium in Sesame Oil Nasal Spray

object_name: Nasal vestibulitis


subject: UMLS:C5448030

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C5448030

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C5448030

object_name: Malignant Solid Neoplasm


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: hyperaldosteronism


subject: CHEBI:3181

object_name: hypertension


subject: CHEBI:3181

object_name: Hypertension, CTCAE


subject: UMLS:C4724252

subject_name: fluorouracil injection

object_name: prurigo nodularis


subject: UMLS:C1655276

subject_name: T-KI

object_name: Unresectable Hepatocellular Carcinoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Bacteremia caused by Staphylococcus aureus


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: Vasodilatory shock


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:32139

object_name: Obstetric Labor Complications


subject: CHEBI:32139

object_name: induced; birth


subject: CHEBI:32139

object_name: pregnancy related


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Multiple myeloma progression


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C4224872

subject_name: Taltz

object_name: idiopathic subglottic stenosis


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Pain during injection


subject: CHEBI:135552

subject_name: Prucalopride

object_name: Dysphagia


subject: CHEBI:135552

object_name: Dysphagia, CTCAE


subject: CHEBI:135552

object_name: Ineffective esophageal peristalsis


subject: PUBCHEM.COMPOUND:135351887

subject_name: PALAZESTRANT

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:135351887

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:135351887

object_name: breast cancer


subject: UNII:VU35KM56Q4


subject: UNII:VU35KM56Q4


subject: UNII:VU35KM56Q4


subject: CHEBI:16302

object_name: respiratory distress syndrome in premature infants


subject: CHEBI:16302

object_name: adult acute respiratory distress syndrome


subject: CHEBI:16302

object_name: newborn respiratory distress syndrome


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:12777


subject: CHEBI:12777


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: CHEBI:139072

object_name: pervasive developmental disorder


subject: CHEBI:139072

object_name: autism


subject: CHEBI:139072

object_name: autism spectrum disorder


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8802

subject_name: Remifentanil

object_name: bariatric surgery candidate


subject: CHEBI:6456


subject: UMLS:C5667026

subject_name: Hpk1 Inhibitor PRJ1-3024

object_name: melanoma


subject: DRUGBANK:DB17107

subject_name: Lifileucel

object_name: pleural mesothelioma


subject: DRUGBANK:DB17107

object_name: malignant pleural mesothelioma


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599


subject: CHEBI:63599


subject: UMLS:C1882421

subject_name: defined green tea catechin extract

object_name: lung cancer


subject: UMLS:C1882421

object_name: lung neoplasm


subject: UMLS:C1882421

object_name: lung carcinoma


subject: UMLS:C1882421

object_name: precancerous condition


subject: UMLS:C1882421

object_name: nicotine dependence


subject: UNII:CMJ4GT6MRD

object_name: Alzheimer disease


subject: PUBCHEM.COMPOUND:2367

subject_name: Betnesol

object_name: adenoviridae infectious disease


subject: UMLS:C0005313

subject_name: Bentelan


subject: UNII:OGN7X90BT8

subject_name: Lenabasum

object_name: cystic fibrosis


subject: UMLS:C5854073


subject: UMLS:C1126285

subject_name: oxycodone 10 mg

object_name: Burn injury


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: fibrosis


subject: CHEBI:9667

subject_name: Triamcinolone


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: bone neoplasm


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Surgical procedure finding


subject: CHEBI:72564

subject_name: Temozolomide


subject: UNII:FC5AAH89R5

subject_name: Benzolamide

object_name: glioblastoma


subject: UNII:FC5AAH89R5

object_name: Childhood Glioblastoma


subject: UNII:FC5AAH89R5

object_name: adult glioblastoma


subject: UNII:FC5AAH89R5

object_name: High grade glioma


subject: UNII:FC5AAH89R5

object_name: malignant glioma


subject: UNII:FC5AAH89R5


subject: CHEBI:52993

subject_name: Lormetazepam

object_name: substance-related disorder


subject: CHEBI:6539

subject_name: Lorazepam


subject: UMLS:C5666863

object_name: familial adenomatous polyposis 1


subject: UMLS:C5666863

object_name: classic familial adenomatous polyposis


subject: UMLS:C5666863

object_name: Adenomatous colonic polyposis


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: bronchopulmonary dysplasia


subject: UMLS:C0085297

object_name: Bronchopulmonary Dysplasia, AE


subject: UNII:DWN2WN457X

subject_name: Dexamethasone acetate monohydrate

object_name: T-cell lymphoma refractory


subject: UNII:DWN2WN457X

object_name: T-Cell Lymphoma


subject: UNII:DWN2WN457X

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:DWN2WN457X

object_name: T-cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:3680

subject_name: Dexamethasone acetate


subject: PUBCHEM.COMPOUND:3680


subject: PUBCHEM.COMPOUND:3680


subject: PUBCHEM.COMPOUND:3680


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: CHEBI:64030

subject_name: tetrabenazine

object_name: Hyperkinetic movement disorder


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: Stage IVB Prostate Cancer AJCC v8


subject: CHEBI:31355

subject_name: Carboplatin


subject: UNII:6N79I7X5II

subject_name: VALEMETOSTAT TOSYLATE


subject: UNII:6N79I7X5II

object_name: castration-resistant prostate carcinoma


subject: UMLS:C5238968

subject_name: Valemetostat Tosylate


subject: UMLS:C5238968


subject: CHEBI:7421

subject_name: NAC

object_name: AIDS


subject: CHEBI:7421

object_name: pulmonary tuberculosis


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:132082

subject_name: Entinostat

object_name: T-cell lymphoma stage IV


subject: CHEBI:132082

object_name: B-cell lymphoma stage IV


subject: CHEBI:132082

object_name: T-cell lymphoma stage III


subject: CHEBI:132082

object_name: B-cell lymphoma stage III


subject: CHEBI:132082

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:132082

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:95082

subject_name: Molibresib

object_name: Advanced Lymphoma


subject: CHEBI:95082

object_name: Refractory Lymphoma


subject: CHEBI:95082

object_name: T-cell lymphoma refractory


subject: CHEBI:95082

object_name: B-cell lymphoma refractory


subject: CHEBI:95082

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:95082

object_name: Refractory Pancreatic Carcinoma


subject: CHEBI:95082

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:95082


subject: CHEBI:95082


subject: CHEBI:95082

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:95082

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:95082


subject: CHEBI:95082


subject: CHEBI:95082

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:95082


subject: CHEBI:95082


subject: CHEBI:95082

object_name: Pancreatic carcinoma non-resectable


subject: PUBCHEM.COMPOUND:52934829


subject: PUBCHEM.COMPOUND:52934829


subject: PUBCHEM.COMPOUND:52934829


subject: PUBCHEM.COMPOUND:52934829


subject: PUBCHEM.COMPOUND:52934829


subject: PUBCHEM.COMPOUND:52934829


subject: PUBCHEM.COMPOUND:52934829


subject: PUBCHEM.COMPOUND:52934829

object_name: T-cell lymphoma stage IV


subject: PUBCHEM.COMPOUND:52934829

object_name: B-cell lymphoma stage IV


subject: PUBCHEM.COMPOUND:52934829


subject: PUBCHEM.COMPOUND:52934829


subject: PUBCHEM.COMPOUND:52934829

object_name: T-cell lymphoma stage III


subject: PUBCHEM.COMPOUND:52934829

object_name: B-cell lymphoma stage III


subject: PUBCHEM.COMPOUND:52934829


subject: PUBCHEM.COMPOUND:52934829

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:52934829

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:52934829


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:7931

subject_name: Paricalcitol


subject: UMLS:C1170183

subject_name: Copegus

object_name: HIV infection


subject: CHEBI:30429

subject_name: Indium

object_name: neuroendocrine neoplasm


subject: CHEBI:31485

subject_name: Difluprednate

object_name: anterior uveitis


subject: UNII:2NDX4B6N8F

subject_name: HA 22

object_name: childhood acute lymphoblastic leukemia


subject: UNII:2NDX4B6N8F

object_name: adult acute lymphoblastic leukemia


subject: UMLS:C2346797


subject: UMLS:C2346797


subject: CHEBI:180653

subject_name: Molnupiravir

object_name: respiratory syncytial virus infectious disease


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Interstitial lung fibrosis


subject: PUBCHEM.COMPOUND:70789204

object_name: Graft dysfunction


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Agitation, CTCAE 3.0


subject: UMLS:C1527137

object_name: Agitation


subject: UMLS:C1527137

object_name: Agitation, CTCAE 5.0


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:6950

subject_name: Mirtazapine


subject: CHEBI:6950


subject: CHEBI:6950


subject: UMLS:C1707048

subject_name: broccoli sprout extract

object_name: asthma


subject: UMLS:C1707048

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C1707048

object_name: COPD, severe early onset


subject: UMLS:C1707048

object_name: chronic obstructive pulmonary disease


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: sarcoma


subject: UMLS:C3898831

object_name: soft tissue sarcoma


subject: CHEBI:7773

subject_name: Ondansetron

object_name: overdose


subject: CHEBI:7773

object_name: Overdose


subject: CHEBI:22198

subject_name: acetylcysteine


subject: CHEBI:22198


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:17561


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin

object_name: adult lymphoma


subject: UMLS:C0376541

object_name: lymphoma


subject: UMLS:C0376541

object_name: pediatric lymphoma


subject: CHEBI:167656

subject_name: Brivanib alaninate

object_name: digestive system neoplasm


subject: CHEBI:167656

object_name: Neoplasm of the gastrointestinal tract


subject: UMLS:C1701190


subject: UMLS:C1701190


subject: CHEBI:63450

subject_name: Masitinib

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:63450

object_name: amyotrophic lateral sclerosis


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Rheumatic mitral stenosis


subject: UNII:C8ADC441ME

object_name: Mitral stenosis


subject: UMLS:C4721943

object_name: ovarian cancer


subject: UMLS:C4721943

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297704

object_name: small cell lung carcinoma


subject: UMLS:C3896899


subject: CHEBI:83766

subject_name: Olaparib

object_name: Refractory acute myeloid leukemia


subject: CHEBI:83766

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:83766

object_name: acute myeloid leukemia


subject: CHEBI:83766

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:83766

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:83766

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:83766

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:83766

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:83766

object_name: Treatment related acute myeloid leukaemia


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: urinary bladder small cell neuroendocrine carcinoma


subject: UMLS:C3896806


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: Low back pain


subject: UMLS:C0051764

subject_name: Ampligen

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: UNII:KE63TTO7WK

subject_name: Sisunatovir

object_name: respiratory syncytial virus infectious disease


subject: UNII:H4C81M8YYW

object_name: post-traumatic stress disorder


subject: CHEBI:305790

subject_name: thyroxine

object_name: diabetes mellitus


subject: UMLS:C5557250

subject_name: Adenosine A2B Receptor Antagonist TT-4

object_name: liver carcinoma


subject: UMLS:C5557250

object_name: pancreatic neoplasm


subject: UMLS:C5557250

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5557250

object_name: malignant pancreatic neoplasm


subject: UMLS:C5557250

object_name: colorectal cancer


subject: UMLS:C5557250

object_name: colorectal carcinoma


subject: UMLS:C5557250

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5557250

object_name: Stomach cancer


subject: UMLS:C5557250

object_name: gastric cancer


subject: GTOPDB:2479

subject_name: HCl

object_name: endogenous depression


subject: GTOPDB:2479

object_name: major depressive disorder


subject: UMLS:C1512523

subject_name: hydrochloride


subject: UMLS:C1512523


subject: UMLS:C0443985

subject_name: Flinders medical centre-7 marker


subject: UMLS:C0443985


subject: CHEBI:17883

subject_name: Hydrochloric acid


subject: CHEBI:17883


subject: UMLS:C1971786

subject_name: Extended Release Tablets Brand Name


subject: UMLS:C1971786


subject: MESH:C476033

subject_name: Maharishi Amrit Kalash

object_name: coronary artery disorder


subject: MESH:C476033

object_name: coronary atherosclerosis


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: reported history of cataract surgery


subject: UNII:K27MHH614O

subject_name: mitoquinol

object_name: preeclampsia


subject: UNII:K27MHH614O

object_name: Pregnant


subject: CHEBI:16236

subject_name: Ethanol

object_name: prostate carcinoma


subject: CHEBI:16236

object_name: prostate cancer


subject: UMLS:C0360094

subject_name: iv lidocaine


subject: UMLS:C0360094


subject: GTOPDB:8935

subject_name: lenzilumab

object_name: chronic myelomonocytic leukemia


subject: CHEMBL.COMPOUND:CHEMBL3707325

subject_name: LENZILUMAB


subject: UMLS:C4087043


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Liver transplant failure and rejection


subject: UMLS:C0376196

subject_name: Opiates

object_name: substance withdrawal syndrome


subject: MESH:D053610

subject_name: Opiate Alkaloids


subject: UMLS:C3827143

subject_name: Cetuximab-IRDye 800CW

object_name: Neck Carcinoma


subject: UMLS:C3827143

object_name: head and neck neoplasm


subject: UMLS:C3827143

object_name: head and neck cancer


subject: UMLS:C2740325

subject_name: Xiaflex

object_name: Dupuytren's contracture (physical finding)


subject: CHEBI:3380

subject_name: Captopril

object_name: pure autonomic failure


subject: CHEBI:3380

object_name: multiple system atrophy


subject: UMLS:C0006938

subject_name: captopril


subject: UMLS:C0006938


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: arthroplasty; complications


subject: CHEBI:94518

object_name: Intraoperative Complication


subject: CHEBI:94518

object_name: SHOULDER JOINT DISEASE


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: type 1 diabetes mellitus 1


subject: UMLS:C5708868

subject_name: Cretostimogene Grenadenorepvec

object_name: superficial urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:3685

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: PUBCHEM.COMPOUND:3685

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:3685

object_name: Alkylating Agent-Related Acute Myeloid Leukemia


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: GTOPDB:9310

subject_name: lirilumab

object_name: Solid Neoplasm


subject: UNII:S9XDI9W918

subject_name: LIRILUMAB


subject: UMLS:C3641620


subject: CHEBI:8884

subject_name: Rocuronium

object_name: bladder tumor


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: LUMBAR SPINE DISC HERNIATION


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:32599


subject: UMLS:C4279730

object_name: Alzheimer disease


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Cognitive impairment


subject: CHEBI:135765

subject_name: Methylprednisolone hemisuccinate

object_name: bacterial pneumonia


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UMLS:C3900015

subject_name: Artemether Sublingual Spray

object_name: Plasmodium falciparum malaria


subject: CHEBI:91370

object_name: pancreatic neoplasm


subject: CHEBI:91370

object_name: malignant pancreatic neoplasm


subject: CHEBI:91370

object_name: prostate cancer


subject: CHEBI:91370

object_name: prostate neoplasm


subject: CHEBI:91370

object_name: head and neck neoplasm


subject: CHEBI:91370

object_name: head and neck cancer


subject: MESH:C573150


subject: MESH:C573150


subject: MESH:C573150


subject: MESH:C573150


subject: MESH:C573150


subject: MESH:C573150


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: fallopian tube carcinoma


subject: UNII:28X28X9OKV

object_name: fallopian tube cancer


subject: UNII:28X28X9OKV

object_name: primary peritoneal carcinoma


subject: UNII:28X28X9OKV

object_name: papillary serous cystadenocarcinoma


subject: UNII:28X28X9OKV

object_name: peritoneal carcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:34605

object_name: fragile X syndrome


subject: CHEBI:34605

object_name: pervasive developmental disorder


subject: CHEBI:34605

object_name: autism


subject: UMLS:C0723892

subject_name: Tricom brand of acetaminophen / chlorpheniramine / pseudoephedrine


subject: UMLS:C1523982

subject_name: TRIad of COstimulatory Molecules (B7-1, ICAM-1, LFA-3)


subject: PUBCHEM.COMPOUND:73437646

subject_name: deutetrabenazine

object_name: Dystonia, Primary


subject: CHEBI:3286

subject_name: Cabergoline

object_name: Androgen excess


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: female infertility


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: Metastatic Bile Duct Carcinoma


subject: UMLS:C3658787

object_name: Head and neck cancer metastatic


subject: UMLS:C3658787

object_name: Recurrent Malignant Head and Neck Neoplasm


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: impotence


subject: CHEBI:28787

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:28787

object_name: Erectile dysfunction


subject: UNII:3B974D670O

object_name: Microvascular coronary artery disease


subject: PUBCHEM.COMPOUND:3370

subject_name: Fludrocortisone acetate

object_name: metastatic prostate carcinoma


subject: CHEBI:50885

subject_name: Fludrocortisone


subject: CHEBI:16962

subject_name: Cortisone


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: PUBCHEM.COMPOUND:135151902

subject_name: OPEVESOSTAT


subject: DRUGBANK:DB18818

subject_name: Opevesostat


subject: UMLS:C5854501

subject_name: Anti-PD-L1/Anti-VEGF-A Bispecific Antibody PM8002

object_name: Primary malignant neoplasm


subject: UMLS:C5854501

object_name: cancer


subject: UMLS:C5854501

object_name: childhood malignant neoplasm


subject: UMLS:C5854501

object_name: Malignant obstetric neoplasm


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: Unresectable Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: Stage IV Soft Tissue Sarcoma AJCC v7


subject: PUBCHEM.COMPOUND:49865963

object_name: Stage III Soft Tissue Sarcoma AJCC v7


subject: PUBCHEM.COMPOUND:49865963

object_name: round cell liposarcoma


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: CHEBI:4887

subject_name: Ethosuximide


subject: GTOPDB:7394

subject_name: gevokizumab

object_name: autoimmune inner ear disease


subject: CHEMBL.COMPOUND:CHEMBL1743026

subject_name: GEVOKIZUMAB


subject: UMLS:C3179523


subject: CHEBI:80271

subject_name: Glp-2 [MI]

object_name: Intestinal Failure


subject: PUBCHEM.COMPOUND:155817441

subject_name: glucagon-like peptide 2


subject: PUBCHEM.COMPOUND:155817441

object_name: short bowel syndrome


subject: PUBCHEM.COMPOUND:90488756

subject_name: GLP-2 (rat)


subject: PUBCHEM.COMPOUND:90488756


subject: UMLS:C0912332

subject_name: Glucagon-Like Peptide 2


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: Recurrent Brain Neoplasm


subject: CHEBI:47519

object_name: Intracranial glioma


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole


subject: PUBCHEM.COMPOUND:147912


subject: PUBCHEM.COMPOUND:147912

object_name: Advanced cancer


subject: CHEBI:71417

subject_name: Procarbazine


subject: CHEBI:71417


subject: CHEBI:71417


subject: UMLS:C0935965

object_name: Carcinoma breast stage IV


subject: UMLS:C0935965

object_name: Childhood Breast Carcinoma


subject: UMLS:C0935965

object_name: breast carcinoma


subject: UMLS:C0935965

object_name: breast cancer


subject: CHEBI:57858

subject_name: atropinium

object_name: cholelithiasis


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:15407

subject_name: Ephedrine


subject: CHEBI:4856

subject_name: Esmolol


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:5494

subject_name: ritropirronium bromide


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:7514

subject_name: Neostigmine


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:9939

subject_name: Vecuronium


subject: MESH:C576493

subject_name: Meopa

object_name: Presenile dementia


subject: MESH:C576493

object_name: dementia


subject: PUBCHEM.COMPOUND:139416847

subject_name: ROCBRUTINIB

object_name: diffuse large B-cell lymphoma


subject: DRUGBANK:DB19445

subject_name: Rocbrutinib


subject: UNII:386012Z45S

subject_name: Linerixibat

object_name: cholestasis


subject: CHEBI:36080

subject_name: protein

object_name: post operative nausea and vomiting


subject: UMLS:C0033684

subject_name: Proteins


subject: PR:000000001


subject: UMLS:C4743433

subject_name: onabotulinum toxin A

object_name: Drooling


subject: UNII:PJX9GH268R

object_name: arthritis


subject: UNII:PJX9GH268R

object_name: Arthritis, CTCAE


subject: CHEBI:74705

subject_name: Met-Leu

object_name: acute kidney failure


subject: CHEBI:74705

object_name: Acute Kidney Injury, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UNII:N65WC8PXDD

subject_name: Xevinapant

object_name: Recurrent Malignant Glioma


subject: CHEBI:197401


subject: CHEBI:9570

subject_name: Thiotepa

object_name: extranodal nasal NK/T cell lymphoma


subject: CHEBI:27470

subject_name: Folic acid

object_name: gingival overgrowth


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C4309517

object_name: Neck Carcinoma


subject: UMLS:C4309517

object_name: head and neck neoplasm


subject: UMLS:C4309517

object_name: head and neck cancer


subject: CHEBI:32696

object_name: peripheral arterial disease


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:157844

subject_name: Glu-Arg

object_name: Diabetic Neuralgia


subject: CHEBI:157844

object_name: diabetic polyneuropathy


subject: CHEBI:33379

subject_name: erbium


subject: CHEBI:33379


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: UMLS:C5441529


subject: PR:000007204

subject_name: estrogen receptor


subject: PR:000007204


subject: PUBCHEM.COMPOUND:66586232

object_name: bacteriemia


subject: PUBCHEM.COMPOUND:66586232

object_name: Bacteremia, CTCAE


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: UMLS:C1261556

subject_name: Iodine tincture


subject: UMLS:C1261556


subject: CHEBI:185135

subject_name: Polyvidone


subject: CHEBI:185135


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:8347


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: atrial fibrillation


subject: CHEBI:26710

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:26710

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:26710

object_name: rapid ventricular response


subject: CHEBI:26710

object_name: Drug-induced hypotension


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: pulmonary hypertension


subject: CHEBI:18361

object_name: Helicobacter pylori infection


subject: CHEBI:53266

subject_name: poly(propylene imine) macromolecule


subject: CHEBI:35782

subject_name: diphosphate ion


subject: CHEBI:60614

subject_name: poly(propylene imine) polymer


subject: CHEBI:29888

subject_name: Pyrophosphate


subject: PUBCHEM.COMPOUND:121954

subject_name: Meridol

object_name: gingivitis


subject: PUBCHEM.COMPOUND:121954

object_name: Dental Plaque


subject: PUBCHEM.COMPOUND:121954

object_name: Skin plaque


subject: PUBCHEM.COMPOUND:121954

object_name: Senile plaques


subject: PUBCHEM.COMPOUND:121954

object_name: Plaque (lesion)


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: sickle cell disease


subject: CHEBI:404903

subject_name: Ertapenem

object_name: diverticulitis of colon


subject: CHEBI:404903

object_name: acute disease


subject: UMLS:C4766143

subject_name: Glucagon for Injection

object_name: hypoglycemia


subject: UMLS:C4766143

object_name: Blood glucose below reference range (finding)


subject: UMLS:C4766143

object_name: Hypoglycemia, CTCAE


subject: CHEBI:15407

subject_name: Ephedrine

object_name: Caesarean section


subject: CHEBI:33569

subject_name: noradrenaline


subject: CHEBI:166902


subject: CHEBI:18357

subject_name: Norepinephrine


subject: GTOPDB:12989

subject_name: toripalimab

object_name: lymphoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: PUBCHEM.COMPOUND:584547

subject_name: Methylprednisolone acetate

object_name: calcific tendinitis


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Metastatic Uveal Melanoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: iris melanoma


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Uveal Melanoma


subject: PUBCHEM.COMPOUND:131769963

object_name: ocular melanoma with extraocular extension


subject: PUBCHEM.COMPOUND:131769963

object_name: medium/large size posterior uveal melanoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: PUBCHEM.COMPOUND:139300919

subject_name: CRISUGABALIN

object_name: fibromyalgia


subject: DRUGBANK:DB19300

subject_name: Crisugabalin


subject: CHEMBL.COMPOUND:CHEMBL4802180

subject_name: RECOMBINANT HUMAN THROMBOPOIETIN

object_name: thrombocytopenia due to immune destruction


subject: UMLS:C4726565

subject_name: Fluorescence Imaging Agent IC2000

object_name: Childhood Breast Carcinoma


subject: UMLS:C4726565

object_name: breast carcinoma


subject: UMLS:C4726565

object_name: breast cancer


subject: CHEBI:136019

subject_name: Nalfurafine

object_name: adverse effect


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:3160

object_name: vitiligo


subject: CHEBI:45863

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:45863

object_name: Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:45863

object_name: Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:45863

object_name: Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:45863

object_name: Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:45863

object_name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:45863

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:45863

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:45863

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:45863

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:45863

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: UMLS:C3713905

object_name: Hepatic impairment


subject: CHEBI:49005

subject_name: Deferasirox

object_name: ovarian cancer


subject: CHEBI:49005

object_name: ovarian neoplasm


subject: CHEBI:49005

object_name: ovarian carcinoma


subject: CHEBI:49005

object_name: Childhood Breast Carcinoma


subject: CHEBI:49005

object_name: breast carcinoma


subject: CHEBI:49005

object_name: breast cancer


subject: CHEBI:49005

object_name: Childhood Neuroblastoma


subject: CHEBI:49005

object_name: neuroblastoma


subject: CHEBI:49005

object_name: adult lymphoma


subject: CHEBI:49005

object_name: lymphoma


subject: CHEBI:49005

object_name: pediatric lymphoma


subject: CHEBI:49005

object_name: leukemia


subject: CHEBI:49005

object_name: childhood leukemia


subject: UMLS:C1832026

object_name: Advanced cancer


subject: CHEBI:7772

subject_name: omeprazole

object_name: chronic hepatitis C virus infection


subject: CHEBI:77260

subject_name: Omeprazole


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Diabetic Neuralgia


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C0042210

subject_name: Vaccines

object_name: Adult Solid Neoplasm


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: nongerminomatous germ cell tumor


subject: UNII:DPT0O3T46P

object_name: testicular germ cell tumor


subject: UNII:DPT0O3T46P

object_name: female reproductive system neoplasm


subject: UNII:DPT0O3T46P

object_name: mediastinal cancer


subject: UNII:DPT0O3T46P

object_name: neoplasm of mediastinum


subject: UNII:DPT0O3T46P

object_name: male reproductive system neoplasm


subject: UNII:DPT0O3T46P

object_name: neoplasm of testis


subject: UNII:DPT0O3T46P

object_name: testicular cancer


subject: CHEBI:52993

subject_name: Lormetazepam

object_name: Mania


subject: CHEBI:52993

object_name: Mania, CTCAE


subject: CHEBI:52993

object_name: Manic Disorder


subject: CHEBI:52993

object_name: bipolar disorder


subject: CHEBI:52993

object_name: schizoaffective disorder


subject: CHEBI:52993

object_name: schizophrenia 18


subject: CHEBI:6539

subject_name: Lorazepam


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:182080

subject_name: Pentazocine


subject: CHEBI:182080


subject: CHEBI:182080


subject: CHEBI:182080


subject: CHEBI:182080


subject: CHEBI:182080


subject: CHEBI:182080

object_name: schizophrenia


subject: UNII:464OXX39Y6

subject_name: Dinalbuphine sebacate

object_name: Post-Operative Pain


subject: UNII:464OXX39Y6

object_name: Chronic pain


subject: UNII:464OXX39Y6

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:464OXX39Y6

object_name: obesity


subject: UNII:464OXX39Y6

object_name: Obesity, CTCAE


subject: CHEBI:6706

subject_name: Mecamylamine

object_name: alcohol abuse


subject: CHEBI:6706

object_name: alcohol dependence


subject: PUBCHEM.COMPOUND:146014907

object_name: neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: UMLS:C4329606

subject_name: CTAG1 Antibody


subject: UniProtKB:P78358

subject_name: CTG1B_HUMAN Cancer/testis antigen 1 (sprot)


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: indolent B-cell non-Hodgkin lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594465


subject: UMLS:C4744837


subject: UMLS:C2746145

subject_name: Vpriv

object_name: primary disorders


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Central retinal vein occlusion - ischemic


subject: CHEMBL.COMPOUND:CHEMBL4650469

subject_name: DEPEMOKIMAB

object_name: COPD, severe early onset


subject: CHEMBL.COMPOUND:CHEMBL4650469

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5448037

subject_name: Depemokimab


subject: UMLS:C5448037


subject: CHEBI:50693

subject_name: Milrinone

object_name: Right Ventricular Dysfunction


subject: CHEBI:50693

object_name: Right Ventricular Dysfunction, CTCAE


subject: CHEBI:50693

object_name: End stage heart disease


subject: CHEBI:30780

object_name: impotence


subject: CHEBI:30780

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:30780

object_name: Erectile dysfunction


subject: CHEBI:77383

subject_name: 1,1-bis(phosphonic acid)

object_name: arthralgia generalized


subject: CHEBI:77383

object_name: Osteoporotic Fractures


subject: MESH:D004164

subject_name: Diphosphonates


subject: MESH:D004164


subject: UMLS:C2267018

subject_name: Bisphosphonate [EPC]


subject: UMLS:C2267018


subject: PUBCHEM.COMPOUND:21874242

subject_name: Vinflunine

object_name: Advanced breast cancer


subject: CHEBI:45783

subject_name: Imatinib

object_name: mastocytosis


subject: UMLS:C5669497

subject_name: IRDye800CW-labeled GPC3-targeted Agent

object_name: liver carcinoma


subject: CHEBI:36373

subject_name: vindesine

object_name: metastatic melanoma


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: Depressed mood


subject: CHEBI:2567

object_name: Cancer patients and suicide and depression


subject: CHEBI:2567

object_name: Depressed - symptom


subject: CHEBI:2567

object_name: Depression, CTCAE


subject: CHEBI:184381

subject_name: Bacitracin

object_name: allergic contact dermatitis


subject: UMLS:C3463871

subject_name: Allergen (brand of antipyrine/benzocaine)


subject: UMLS:C3274161

subject_name: Allergen (brand of diphenylpyraline)


subject: MESH:D000485

subject_name: Allergens


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: renal carcinoma


subject: UNII:6XC1PAD3KF

object_name: kidney neoplasm


subject: UNII:6XC1PAD3KF

object_name: kidney cancer


subject: CHEBI:32090

subject_name: Rebamipide

object_name: Acute gastritis


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: Cancer of Neck


subject: UNII:M487QF2F4V

object_name: Cancer of Head


subject: UNII:M487QF2F4V

object_name: Neck Neoplasms


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:49960

subject_name: Vandetanib

object_name: Childhood Glioblastoma


subject: CHEBI:49960

object_name: adult glioblastoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: pediatric angiosarcoma


subject: UNII:PVI5M0M1GW

object_name: angiosarcoma


subject: UNII:PVI5M0M1GW

object_name: Adult Angiosarcoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:33699

subject_name: messenger RNA


subject: CHEBI:33699


subject: CHEBI:33699


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Severe Aplastic Anemia


subject: CHEBI:201431

object_name: severe aplastic anemia


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: choanal atresia


subject: CHEBI:4466

object_name: primary cutaneous amyloidosis


subject: CHEBI:4466

object_name: posterior cortical atrophy


subject: CHEBI:4466

object_name: amyloidosis, primary localized cutaneous, 1


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UMLS:C5440671

subject_name: Lupkynis

object_name: lupus nephritis


subject: CHEBI:2955

subject_name: Azithromycin

object_name: bacterial conjunctivitis


subject: UNII:PVI5M0M1GW

object_name: type 1 diabetes mellitus 1


subject: UNII:PVI5M0M1GW

object_name: type 1 diabetes mellitus


subject: PR:000005932


subject: PR:000005932


subject: UMLS:C0304604

subject_name: Topical form corticosteroids

object_name: chronic rhinosinusitis


subject: UNII:U2I8T43Y7R

subject_name: axicabtagene ciloleucel

object_name: adult lymphoma


subject: UNII:U2I8T43Y7R

object_name: lymphoma


subject: UNII:U2I8T43Y7R

object_name: pediatric lymphoma


subject: UNII:U2I8T43Y7R

object_name: primary central nervous system lymphoma


subject: PUBCHEM.COMPOUND:66660570

subject_name: Evogliptin

object_name: Albuminuria


subject: PUBCHEM.COMPOUND:66660570

object_name: kidney failure


subject: PUBCHEM.COMPOUND:57389748

subject_name: Linagliptin


subject: PUBCHEM.COMPOUND:57389748


subject: CHEBI:9316

subject_name: Sufentanil

object_name: Postoperative delirium


subject: CHEBI:9316

object_name: Emergence Delirium


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: arteriosclerosis disorder


subject: CHEBI:6888

object_name: atherosclerosis


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: Hepatitis D, Chronic


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: retinopathy of prematurity


subject: CHEBI:36005

object_name: exudative vitreoretinopathy 1


subject: CHEBI:36005

object_name: Retinopathy of Prematurity, AE


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:28125


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: skin neoplasm


subject: UMLS:C0919079

object_name: skin cancer


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: UMLS:C5543835

object_name: atopic eczema


subject: CHEBI:3219

subject_name: Bupropion

object_name: psychosis


subject: CHEBI:9123

subject_name: Sertraline


subject: CHEBI:95165

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:4875

subject_name: Etanercept

object_name: acute graft versus host disease


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: UMLS:C0117857

subject_name: Fleet Enema

object_name: HIV infection


subject: GTOPDB:13543

subject_name: inotersen

object_name: familial amyloid neuropathy


subject: GTOPDB:13543

object_name: amyloidosis


subject: GTOPDB:13543

object_name: amyloidosis, hereditary systemic 1


subject: GTOPDB:13543

object_name: classic familial adenomatous polyposis


subject: UNII:0IEO0F56LV

subject_name: Inotersen


subject: UNII:0IEO0F56LV


subject: UNII:0IEO0F56LV


subject: UNII:0IEO0F56LV


subject: DRUGBANK:DB17601

subject_name: Ixmyelocel-T

object_name: osteonecrosis


subject: DRUGBANK:DB17601

object_name: avascular necrosis


subject: DRUGBANK:DB17601

object_name: Osteonecrosis, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2108628

subject_name: PACLITAXEL POLIGLUMEX

object_name: undifferentiated ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Ovarian cancer stage IV


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Ovarian cancer stage III


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: Malignant Ovarian Mixed Epithelial Tumor


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: ovarian seromucinous carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: ovarian Brenner tumor


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: ovarian endometrioid adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: ovarian clear cell cystadenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: ovarian serous cystadenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: ovarian mucinous cystadenocarcinoma


subject: UNII:19J3781LPM

subject_name: Itacitinib

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:19J3781LPM

object_name: non-Hodgkin lymphoma


subject: UNII:19J3781LPM

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:19J3781LPM

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C1527127

object_name: ovarian neoplasm


subject: UMLS:C0383327


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: acute myeloid leukemia, t(3;5)(q25;q34)


subject: PUBCHEM.COMPOUND:1805

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: UMLS:C5399992


subject: UMLS:C5399992


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: PUBCHEM.COMPOUND:5245480

object_name: interstitial lung disease 1


subject: PUBCHEM.COMPOUND:5245480

object_name: interstitial lung disease 2


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: CHEBI:49086

object_name: Mania


subject: CHEBI:49086

object_name: cocaine abuse


subject: CHEBI:49086

object_name: Mania, CTCAE


subject: CHEBI:16436

subject_name: Citicoline


subject: CHEBI:16436


subject: CHEBI:16436


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:135925

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:135925

object_name: morbid obesity


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Myelodysplasia


subject: UMLS:C3641122


subject: UMLS:C3897088

subject_name: Oral Azacitidine


subject: CHEBI:4356

subject_name: Deferoxamine

object_name: Acute Stroke


subject: CHEBI:4356

object_name: Acute Stroke Related to COVID-19


subject: CHEBI:23359

subject_name: colchicine

object_name: intracerebral hemorrhage


subject: CHEBI:23359


subject: CHEBI:23359


subject: UMLS:C5666933

subject_name: PM 14

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:3745

subject_name: clindamycin

object_name: Impacted molars


subject: CHEBI:3745

object_name: Impacted third molar tooth


subject: UMLS:C0699672

subject_name: Dalacin C


subject: UMLS:C0699672


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: primitive neuroectodermal tumor


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: acute coronary syndrome


subject: MESH:C000613826

object_name: Childhood Breast Carcinoma


subject: MESH:C000613826

object_name: breast carcinoma


subject: MESH:C000613826

object_name: breast cancer


subject: UMLS:C1699394

subject_name: Hylenex

object_name: Hypercholesterolemia


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: anthrax disease


subject: MESH:C000607290

subject_name: AMG 595

object_name: glioblastoma


subject: MESH:C000607290

object_name: Brain Stem Glioblastoma


subject: MESH:C000607290

object_name: glioma susceptibility 1


subject: MESH:C000607290

object_name: anaplastic astrocytoma


subject: UMLS:C3274618


subject: UMLS:C3274618


subject: UMLS:C3274618


subject: UMLS:C3274618


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine

object_name: adult acute myeloid leukemia


subject: UNII:39IS23Q1EW

object_name: childhood acute myeloid leukemia


subject: CHEBI:4856

subject_name: Esmolol

object_name: primary dysautonomia


subject: CHEBI:4856

object_name: dysautonomia


subject: CHEBI:4856

object_name: autonomic nervous system disorder


subject: CHEBI:4856

object_name: traumatic encephalopathy


subject: CHEBI:4856

object_name: traumatic brain injury


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Phelan-McDermid syndrome


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:135964

subject_name: Clevudine


subject: UNII:IZT740JY57

object_name: exocrine pancreatic carcinoma


subject: UNII:IZT740JY57

object_name: malignant pancreatic neoplasm


subject: UNII:IZT740JY57

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:IZT740JY57

object_name: stage IV pancreatic cancer


subject: UNII:IZT740JY57

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C3501154


subject: UMLS:C3501154


subject: UMLS:C3501154


subject: UMLS:C3501154


subject: UMLS:C3501154


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: lung disorder


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Fused cervical vertebrae


subject: CHEBI:3215

object_name: Myofacial Pain


subject: CHEBI:3215

object_name: Neck pain


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: esophageal adenocarcinoma


subject: UNII:6QVL057INT

object_name: lung adenocarcinoma


subject: UNII:6QVL057INT

object_name: cervical adenocarcinoma


subject: UNII:6QVL057INT

object_name: adenocarcinoma


subject: UNII:6QVL057INT

object_name: bile duct adenocarcinoma


subject: UNII:6QVL057INT

object_name: gastric adenocarcinoma


subject: UNII:6QVL057INT

object_name: pancreatic adenocarcinoma


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: PUBCHEM.COMPOUND:166625217

subject_name: MOTIXAFORTIDE


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:166625217

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:166625217

object_name: malignant pancreatic neoplasm


subject: CHEBI:73579

subject_name: Leu-Val

object_name: liver carcinoma


subject: CHEBI:194537

subject_name: Livermorium


subject: UMLS:C1881413

subject_name: Liposome Vesicle


subject: PR:000003915

subject_name: delta-aminolevulinic acid dehydratase


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan

object_name: colorectal cancer


subject: GTOPDB:13791

object_name: colorectal carcinoma


subject: GTOPDB:13791

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: GTOPDB:13791

object_name: biliary tract cancer


subject: GTOPDB:13791

object_name: pancreatic ductal adenocarcinoma


subject: GTOPDB:13791


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UNII:3DV5TD1VL3


subject: UNII:3DV5TD1VL3


subject: UNII:3DV5TD1VL3


subject: UNII:3DV5TD1VL3


subject: UNII:3DV5TD1VL3


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: UMLS:C5237963


subject: UMLS:C5237963


subject: UMLS:C5237963


subject: UMLS:C5237963


subject: UMLS:C5237963


subject: UMLS:C3485429

subject_name: Probiotic Formula

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3485429

object_name: obesity


subject: UMLS:C3485429

object_name: Obesity, CTCAE


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Myocardial injury


subject: CHEBI:60802

object_name: Cardiac dysfunction


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: Anterior Cruciate Ligament Tear


subject: CHEBI:9667

object_name: Tibial Meniscus Injuries


subject: CHEBI:9667

object_name: Torn Tibial Meniscus


subject: CHEBI:9667

object_name: Tibial Meniscus Tears


subject: UNII:4E4EWP9DJQ

subject_name: DOCIRBRUTINIB

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:4E4EWP9DJQ

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:4E4EWP9DJQ

object_name: non-Hodgkin lymphoma


subject: UNII:4E4EWP9DJQ

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:4E4EWP9DJQ

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:4E4EWP9DJQ

object_name: mantle cell lymphoma


subject: UNII:4E4EWP9DJQ

object_name: follicular lymphoma


subject: UNII:4E4EWP9DJQ

object_name: marginal zone lymphoma


subject: UNII:4E4EWP9DJQ

object_name: MALT lymphoma


subject: UNII:4E4EWP9DJQ

object_name: B-Cell Malignant Neoplasm


subject: UNII:4E4EWP9DJQ

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:125628

subject_name: Alisertib

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:125628

object_name: Adult Mixed Glioma


subject: CHEBI:125628

object_name: adult brainstem glioma


subject: CHEBI:125628

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:125628

object_name: Adult Subependymal Giant Cell Astrocytoma


subject: CHEBI:125628

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:125628

object_name: adult oligodendroglioma


subject: CHEBI:125628

object_name: Adult Pineal Gland Astrocytoma


subject: CHEBI:125628

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:125628

object_name: adult anaplastic ependymoma


subject: CHEBI:125628

object_name: Adult Pilocytic Astrocytoma


subject: CHEBI:125628

object_name: Adult Diffuse Astrocytoma


subject: CHEBI:125628

object_name: adult glioblastoma


subject: CHEBI:125628

object_name: Adult Gliosarcoma


subject: UMLS:C2984213

object_name: prostate carcinoma


subject: UMLS:C2984213

object_name: prostate cancer


subject: UMLS:C2984213

object_name: Childhood Breast Carcinoma


subject: UMLS:C2984213

object_name: breast carcinoma


subject: UMLS:C2984213

object_name: breast cancer


subject: UMLS:C2984213

object_name: ovarian cancer


subject: UMLS:C2984213

object_name: ovarian neoplasm


subject: UMLS:C2984213

object_name: ovarian carcinoma


subject: UMLS:C0017132

subject_name: Gastric Inhibitory Polypeptide

object_name: diabetes mellitus


subject: CHEBI:43871

subject_name: Fasudil

object_name: arteriosclerosis disorder


subject: CHEBI:43871

object_name: atherosclerosis


subject: CHEBI:43871

object_name: Hypercholesterolemia


subject: UMLS:C5226617

object_name: myasthenia gravis


subject: UMLS:C5226617

object_name: Myasthenia Gravis, CTCAE


subject: PUBCHEM.COMPOUND:72995949

subject_name: Voclosporin

object_name: lupus nephritis


subject: CHEBI:74088

object_name: multiple sclerosis


subject: CHEBI:74007


subject: CHEBI:73805

subject_name: Ala-Ile


subject: PR:000015526

subject_name: transcription factor Spi-C


subject: UMLS:C0033374

subject_name: Prolactin-Releasing Hormone


subject: PUBCHEM.COMPOUND:9838675

subject_name: ARTEMISININ

object_name: Plasmodium falciparum malaria


subject: MESH:D037621

subject_name: Artemisinins


subject: UNII:TRY8UD4E2H

subject_name: Naphthoquine


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Hospital acquired pneumonia


subject: UMLS:C3661275

object_name: trabecular adenocarcinoma


subject: UMLS:C3661275

object_name: cutaneous neuroendocrine carcinoma


subject: CHEBI:91450

subject_name: Sapanisertib


subject: CHEBI:91450


subject: UMLS:C5418011

subject_name: CSF-1R Inhibitor ABSK021

object_name: chronic graft versus host disease


subject: CHEBI:63581

subject_name: Stavudine

object_name: AIDS dementia


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Endometrial Intraepithelial Neoplasia


subject: PUBCHEM.COMPOUND:70789204

object_name: atypical endometrial hyperplasia


subject: PUBCHEM.COMPOUND:70789204

object_name: FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: chronic granulomatous disease


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: CHEBI:18145

subject_name: Vitamin E

object_name: Hyperuricemia


subject: CHEBI:18145

object_name: Hyperuricemia, CTCAE


subject: UMLS:C4053577

subject_name: Sotevtamab

object_name: Metastatic non-small cell lung cancer


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine

object_name: lung cancer


subject: PUBCHEM.COMPOUND:136924190

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:136924190

object_name: lung carcinoma


subject: CHEBI:197437

subject_name: Mocetinostat


subject: CHEBI:197437


subject: CHEBI:197437


subject: UMLS:C5784639

subject_name: pan-RAF Inhibitor JZP815

object_name: Childhood Solid Neoplasm


subject: UMLS:C5784639

object_name: Adult Solid Neoplasm


subject: UMLS:C5784639

object_name: Solid Neoplasm


subject: UMLS:C5784639

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5784639

object_name: Embolism, Tumor


subject: UMLS:C5784639

object_name: Neoplasm Metastasis


subject: UMLS:C5784639

object_name: Advanced cancer


subject: CHEBI:3423

subject_name: Carmustine

object_name: HIV infection


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: enteropathy-associated T-cell lymphoma


subject: UMLS:C1832035


subject: UMLS:C4706114

object_name: osteoarthritis


subject: CHEBI:30630

subject_name: propylenediamine

object_name: Muscle Atrophy


subject: CHEBI:74754

subject_name: Pro-Asn


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: myasthenia gravis


subject: UNII:4F4X42SYQ6

object_name: Myasthenia Gravis, CTCAE


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: PUBCHEM.COMPOUND:10198924

subject_name: CHOLINE BITARTRATE

object_name: anemia


subject: PUBCHEM.COMPOUND:10198924

object_name: Anemia, CTCAE


subject: CHEBI:16822

subject_name: choline sulfate


subject: CHEBI:16822


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:15354


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: dry eye syndrome


subject: UMLS:C3714501

object_name: Dry Eye, CTCAE


subject: UMLS:C3714501

object_name: Dryness of eye


subject: GTOPDB:4934

subject_name: G-CSF

object_name: hematologic disorder


subject: UMLS:C3661059

object_name: type 2 diabetes mellitus


subject: UMLS:C0003405

subject_name: Antiparkinson Agents

object_name: Parkinson disease


subject: UMLS:C5227816


subject: CHEBI:228302

subject_name: Zuranolone


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Refractory Urothelial Carcinoma


subject: CHEBI:229764

subject_name: Selinexor

object_name: Locally Advanced Urothelial Carcinoma


subject: CHEBI:229764

object_name: Advanced Urothelial Carcinoma


subject: CHEBI:229764

object_name: Metastatic urothelial carcinoma


subject: CHEBI:229764


subject: UMLS:C1138626

subject_name: cocoa extract

object_name: migraine


subject: UMLS:C1138626

object_name: migraine with or without aura, susceptibility to, 1


subject: DRUGBANK:DB10977

subject_name: Cocoa


subject: DRUGBANK:DB10977


subject: UMLS:C4277831

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4277831

object_name: Embolism, Tumor


subject: UMLS:C4277831

object_name: Neoplasm Metastasis


subject: GTOPDB:4934

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: GTOPDB:4934

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: GTOPDB:4934

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: GTOPDB:4934

object_name: adult acute myeloid leukemia with del(5q)


subject: GTOPDB:4934

object_name: Untreated Adult Acute Myeloid Leukemia


subject: GTOPDB:4934

object_name: recurrent adult acute myeloid leukemia


subject: GTOPDB:4934

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: GTOPDB:4934

object_name: Adult Acute Myelomonocytic Leukemia


subject: GTOPDB:4934

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: GTOPDB:4934

object_name: Adult Pure Erythroid Leukemia


subject: GTOPDB:4934

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: GTOPDB:4934

object_name: adult acute monocytic leukemia


subject: GTOPDB:4934

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: GTOPDB:4934

object_name: Adult Acute Monoblastic Leukemia


subject: GTOPDB:4934

object_name: acute megakaryoblastic leukemia in adult


subject: GTOPDB:4934

object_name: Adult Erythroleukemia


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: UMLS:C5235281

subject_name: ALK/ROS1/NTRK/SRC/FAK Multikinase Inhibitor TPX-0005

object_name: adult lymphoma


subject: UMLS:C5235281

object_name: lymphoma


subject: UMLS:C5235281

object_name: pediatric lymphoma


subject: CHEBI:229220

subject_name: Repotrectinib


subject: CHEBI:229220


subject: CHEBI:229220


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Bronchospasm, Exercise-Induced


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:474053

subject_name: Cefazolin

object_name: liver carcinoma


subject: UMLS:C4745029

subject_name: HLX 10

object_name: metastatic colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL5095122

subject_name: FREXALIMAB

object_name: multiple sclerosis


subject: UMLS:C5787323

subject_name: Frexalimab


subject: UNII:9J765S329G

subject_name: L-Thyroxine sodium salt pentahydrate

object_name: Paraquat toxicity


subject: UNII:9J765S329G

object_name: paraquat poisoning


subject: CHEBI:6447

subject_name: levothyroxine sodium hydrate


subject: CHEBI:6447


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: UMLS:C0079691

subject_name: Levothroid


subject: UMLS:C0079691


subject: GTOPDB:6788

subject_name: drotrecogin alfa

object_name: septic shock


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: breast neoplasm


subject: CHEBI:6149

object_name: Bradycardia by ECG Finding


subject: CHEBI:6149

object_name: Bradycardia


subject: CHEBI:6149

object_name: hypotension


subject: CHEBI:6149

object_name: Hypotension, CTCAE


subject: UMLS:C4287663

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297797

object_name: rheumatoid arthritis


subject: UMLS:C5853357


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: deafness


subject: MESH:D000077325

object_name: hearing loss by exam


subject: UMLS:C2715577

object_name: Myelofibrosis due to another disorder


subject: UMLS:C2715577

object_name: platelet membrane fluidity


subject: UMLS:C2715577


subject: UMLS:C2715577

object_name: Post-polycythemia vera myelofibrosis


subject: UMLS:C2715577

object_name: myelofibrosis


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: UMLS:C1176324


subject: UMLS:C1176324


subject: UMLS:C1176324


subject: UMLS:C1176324


subject: UMLS:C1176324


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Langerhans cell histiocytosis


subject: CHEBI:49662

object_name: Langerhans cell histiocytosis specific to childhood


subject: CHEBI:49662

object_name: Langerhans cell histiocytosis specific to adulthood


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: UMLS:C0085297


subject: UMLS:C0085297


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:2208


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Corneal pannus


subject: CHEBI:33313

subject_name: polonium atom

object_name: type 2 diabetes mellitus


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin

object_name: Solid Neoplasm


subject: UNII:IL870Q3Z8I

subject_name: Cobiprostone


subject: UNII:IL870Q3Z8I

object_name: osteoarthritis


subject: UNII:IL870Q3Z8I

object_name: ulcer disease


subject: CHEBI:45783

subject_name: Imatinib

object_name: myeloproliferative neoplasm


subject: UNII:X85G7936GV

subject_name: Abciximab

object_name: brain ischemia


subject: UNII:X85G7936GV

object_name: acute disease


subject: CHEBI:62088

subject_name: Metamizole

object_name: Surgical procedure finding


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: asthma


subject: CHEBI:46195

object_name: Wheezing


subject: CHEBI:46195

object_name: Wheezing, CTCAE


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:114785

subject_name: Erlotinib

object_name: digestive system cancer


subject: CHEBI:49668

subject_name: Gefitinib


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: CHEBI:45783


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:49960

subject_name: Vandetanib


subject: MESH:C000720039

object_name: Drug Interactions


subject: CHEBI:15544

subject_name: Alprostadil

object_name: peripheral arterial disease


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Oesophageal squamous cell carcinoma recurrent


subject: CHEBI:231614

object_name: Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Unresectable Esophageal Squamous Cell Carcinoma


subject: CHEBI:231614

object_name: Squamous cell carcinoma of head and neck metastatic


subject: CHEBI:231614

object_name: Advanced Esophageal Squamous Cell Carcinoma


subject: CHEBI:231614

object_name: Metastatic Esophageal Squamous Cell Carcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:2269

object_name: inclusion conjunctivitis


subject: PUBCHEM.COMPOUND:2269

object_name: trachoma


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: UMLS:C0593510

subject_name: Recombinant human follicle stimulating hormone

object_name: infertility


subject: CHEBI:42588

subject_name: Fenretinide

object_name: primary peritoneal carcinoma


subject: CHEBI:42588

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:42588

object_name: peritoneal carcinoma


subject: CHEBI:42588

object_name: ovarian cancer


subject: CHEBI:42588

object_name: ovarian neoplasm


subject: CHEBI:42588

object_name: ovarian carcinoma


subject: CHEBI:47519

subject_name: Ketoconazole


subject: CHEBI:47519


subject: CHEBI:47519


subject: CHEBI:47519


subject: CHEBI:47519


subject: CHEBI:47519


subject: UNII:4O2AB118LA

subject_name: GRAZOPREVIR

object_name: acute hepatitis C virus infection


subject: CHEBI:132975

subject_name: Grazoprevir


subject: CHEBI:3396

subject_name: Carbidopa-levodopa

object_name: Acute Pain


subject: UMLS:C0353697

subject_name: carbidopa / levodopa


subject: CHEBI:75551


subject: CHEBI:52763


subject: UNII:1XQ871489P

subject_name: Fosmanogepix

object_name: Hepatic impairment


subject: UMLS:C0021745

subject_name: interferon type II

object_name: chronic granulomatous disease


subject: UMLS:C3539881

subject_name: gamma-interferon


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: acute bronchiolitis


subject: UMLS:C0962969

subject_name: RAD 001

object_name: colorectal cancer


subject: UMLS:C0962969

object_name: colorectal carcinoma


subject: UMLS:C0962969

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0962969

object_name: colorectal neoplasm


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Metastatic malignant neoplasm to liver


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: Advanced Prostate Carcinoma


subject: PUBCHEM.COMPOUND:121489720

object_name: pleomorphic adenoma


subject: CHEBI:90936

subject_name: Alectinib

object_name: lymphoproliferative syndrome


subject: CHEBI:90936

object_name: Neoplasms by Histologic Type


subject: CHEBI:90936

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:90936

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:90936

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:90936

object_name: clear cell renal carcinoma


subject: CHEBI:90936

object_name: renal cell adenocarcinoma


subject: CHEBI:90936

object_name: renal cell carcinoma


subject: CHEBI:90936

object_name: Primary malignant neoplasm


subject: CHEBI:90936

object_name: childhood malignant neoplasm


subject: CHEBI:90936

object_name: Malignant obstetric neoplasm


subject: CHEBI:90936

object_name: Childhood Neuroblastoma


subject: CHEBI:90936

object_name: neuroblastoma


subject: CHEBI:90936

object_name: adult lymphoma


subject: CHEBI:90936

object_name: lymphoma


subject: CHEBI:90936

object_name: pediatric lymphoma


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: pancreatic neoplasm


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Cachexia


subject: PR:000030332

subject_name: E3 ubiquitin-protein ligase TRIM31

object_name: multiple sclerosis


subject: PR:000030332

object_name: Clinically isolated syndrome


subject: CHEBI:52717

subject_name: Bortezomib

object_name: EXCESS LMW-DNA


subject: CHEBI:52717

object_name: myasthenia gravis


subject: CHEBI:52717

object_name: Myasthenia Gravis, CTCAE


subject: CHEBI:166975

subject_name: soybean oil

object_name: infertility


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: delirium


subject: CHEBI:9130

object_name: Delirium, CTCAE


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX

object_name: exocrine pancreatic carcinoma


subject: UNII:QEN1X95CIX

object_name: malignant pancreatic neoplasm


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Antioxidative Stress


subject: CHEBI:30314

object_name: Dependence on dialysis due to end stage renal disease


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: HMDB:HMDB0001349

subject_name: Selenium


subject: HMDB:HMDB0001349


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: DRUGBANK:DB15438

subject_name: Artemin

object_name: sciatica


subject: PR:000004331

subject_name: artemin


subject: CHEBI:34650

subject_name: COLISTIMETHATE

object_name: pneumonia


subject: CHEBI:34650

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:34650

object_name: pneumococcal infection


subject: CHEBI:34650

object_name: Pathogen resistance


subject: CHEBI:37943

subject_name: colistin


subject: CHEBI:37943


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Left atrial thrombosis


subject: CHEBI:70752

subject_name: Dabigatran


subject: PUBCHEM.COMPOUND:16131310

subject_name: Hepatitis B Vaccines

object_name: Vaccine adverse reaction


subject: DRUGBANK:DB11627

subject_name: Hepatitis B Vaccine (Recombinant)


subject: UMLS:C2240392


subject: UMLS:C0062527

subject_name: Engerix-B


subject: MESH:D011819

subject_name: Rabies Vaccines


subject: CHEMBL.COMPOUND:CHEMBL2107909

subject_name: RABIES VACCINE


subject: UMLS:C1512511

subject_name: Human Papilloma Virus Vaccine


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Erythema migrans


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: PUBCHEM.COMPOUND:91976570

subject_name: Calcitonin gene-related peptide

object_name: Post-Traumatic Headache


subject: PUBCHEM.COMPOUND:91976570

object_name: Mild Traumatic Brain Injury


subject: UNII:JHB2QIZ69Z

subject_name: CALCITONIN GENE-RELATED PEPTIDE


subject: UNII:JHB2QIZ69Z


subject: UMLS:C5222499

subject_name: Sodium Phosphates Injection

object_name: total parenteral nutrition


subject: GTOPDB:12990

subject_name: sintilimab

object_name: oropharynx squamous cell carcinoma


subject: GTOPDB:12990

object_name: oral cavity squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: CHEBI:71025

subject_name: ulipristal

object_name: Menorrhagia


subject: UMLS:C4489845

subject_name: CANNABIDIOL OIL

object_name: Mixed Dementias


subject: UMLS:C4489845

object_name: vascular dementia


subject: UNII:2R27AB6766

subject_name: Caplacizumab

object_name: Immune thrombotic thrombocytopenia


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: psychologic vaginismus


subject: CHEBI:3160

object_name: vaginismus


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: DS Stage I Plasma Cell Myeloma


subject: UMLS:C0003442

object_name: ISS Stage I Plasma Cell Myeloma


subject: UMLS:C0003442

object_name: DS Stage II Plasma Cell Myeloma


subject: UMLS:C0003442

object_name: ISS Stage II Plasma Cell Myeloma


subject: UMLS:C0003442

object_name: ISS Stage III Plasma Cell Myeloma


subject: UMLS:C0003442

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: brain glioma


subject: UNII:2S9ZZM9Q9V

object_name: Intracranial glioma


subject: CHEBI:172923

subject_name: FLUORESCEIN

object_name: Barrett esophagus


subject: CHEBI:172923

object_name: Heartburn


subject: CHEBI:8452

subject_name: Proflavine


subject: CHEBI:149504

object_name: congenital pulmonary veins atresia or stenosis


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Renal Colic, CTCAE


subject: CHEBI:41879

object_name: renal colic


subject: CHEBI:167574

subject_name: Semaglutide

object_name: stroke disorder


subject: CHEBI:167574

object_name: Stroke (heart beat)


subject: CHEBI:167574

object_name: Stroke, CTCAE


subject: CHEBI:167574

object_name: Acute Stroke


subject: CHEBI:167574

object_name: brain disorder


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Wet age-related macular degeneration


subject: CHEBI:75958

subject_name: solution

object_name: Cough


subject: CHEBI:75958

object_name: Cough, CTCAE


subject: UMLS:C0037633

subject_name: Solutions


subject: UMLS:C0037633


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Platinum-Resistant Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Recurrent Primary Peritoneal Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Fallopian Tube Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: FIGO Stage IVB Ovarian Cancer 2014


subject: PUBCHEM.COMPOUND:2767

object_name: FIGO Stage IVA Ovarian Cancer 2014


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Uterine Corpus Cancer


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:175901

object_name: Stage III Fallopian Tube Cancer AJCC v7


subject: CHEBI:175901

object_name: Stage III Primary Peritoneal Cancer AJCC v7


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:175901

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:175901

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:175901

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:175901

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:175901

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:175901

object_name: Stage IVB Uterine Corpus Cancer AJCC v7


subject: CHEBI:175901

object_name: Stage IVA Uterine Corpus Cancer AJCC v7


subject: CHEBI:175901

object_name: Stage IIIC Uterine Corpus Cancer AJCC v7


subject: CHEBI:175901

object_name: Stage IIIB Uterine Corpus Cancer AJCC v7


subject: CHEBI:175901

object_name: Stage IIIA Uterine Corpus Cancer AJCC v7


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:28748

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:28748

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748

object_name: FIGO Stage IVB Ovarian Cancer 2014


subject: CHEBI:28748

object_name: FIGO Stage IVA Ovarian Cancer 2014


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748

object_name: Stage IV Uterine Corpus Cancer


subject: CHEBI:28748

object_name: Stage III Uterine Corpus Cancer


subject: CHEBI:28748


subject: CHEBI:48814

subject_name: Chloral

object_name: traumatic encephalopathy


subject: CHEBI:48814

object_name: traumatic brain injury


subject: CHEBI:48814

object_name: computed tomography


subject: CHEBI:6931

subject_name: Midazolam


subject: UMLS:C5446549

subject_name: Adenosine A2A Receptor Antagonist CS3005

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:31709

subject_name: Iohexol

object_name: Transsexual (finding)


subject: CHEBI:31709

object_name: Transgender


subject: CHEBI:31709

object_name: Renal Function


subject: CHEBI:31709

object_name: Encounter due to hormone replacement therapy


subject: UMLS:C4510275

subject_name: Sulfur hexafluoride lipid microsphere

object_name: appendicitis


subject: CHEBI:230791

subject_name: tributyrylglycerol

object_name: prostate carcinoma


subject: CHEBI:230791

object_name: prostate cancer


subject: CHEBI:230791

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:35020

subject_name: Tributyrin


subject: CHEBI:35020


subject: CHEBI:35020


subject: CHEBI:55379

subject_name: camphorsulfonic acid

object_name: Myelodysplasia


subject: PR:000007170

subject_name: DNA excision repair protein ERCC-8


subject: UMLS:C0125069

subject_name: L-ornithine L-aspartate

object_name: Decompensated cirrhosis of liver


subject: UMLS:C0125069

object_name: portal hypertension


subject: UMLS:C0125069

object_name: Portal Hypertension, CTCAE


subject: UMLS:C0125069

object_name: Refractory ascites


subject: UMLS:C0125069

object_name: Bleeding varices


subject: UMLS:C1832001

object_name: brain cancer


subject: UMLS:C1832001

object_name: brain neoplasm


subject: CHEBI:82339

subject_name: Merphalan

object_name: Metastatic Breast Carcinoma in the Liver


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid


subject: CHEBI:63587

subject_name: Eribulin


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: CHEBI:93786


subject: CHEBI:142431

subject_name: Praliciguat

object_name: focal segmental glomerulosclerosis


subject: CHEBI:63632

subject_name: Topotecan

object_name: endometrium neoplasm


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: acute pancreatitis


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Genitourinary syndrome of menopause


subject: CHEBI:144903

object_name: Childhood Breast Carcinoma


subject: CHEBI:144903

object_name: breast carcinoma


subject: CHEBI:144903

object_name: breast cancer


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: PR:000003551


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000001886


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000030465


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: PR:000013555


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: PR:000032963


subject: PR:000032963


subject: CHEBI:125427


subject: CHEBI:125427


subject: CHEBI:125427


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: CHEBI:17823


subject: GTOPDB:12417

subject_name: abelacimab

object_name: atrial fibrillation